Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer.
For more details on financing and valuation for Lycera, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
To read this article and more news on Lycera, register or login.
